MoneyWorks4Me

Transgene Biotech submits copy of limited review report

18 Feb 2013 Evaluate

Transgene Biotech has submitted a copy of the limited review report for the period ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 44.10
Prime Focus 272.55
Knowledge RealtyTrt. 111.19
Indegene 571.50
Syngene Internatl. 366.90
View more..